Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunomodulated rescue immune tolerance induction in hemophilia A with refractory inhibitors
2009-016029-32Phase 4Active
- Sponsor
- Angelo Bianchi Bonomi Hemophilia and Thrombosis Center
- Start
- Nov 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of prednisolone and methylprednisolone in hemophilia A, sponsored by Angelo Bianchi Bonomi Hemophilia and Thrombosis Center. Primary endpoints: Complete success, Partial response and 2 more. Started Nov 2009; status: active.
02
Drugs
prednisolonemethylprednisolone
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2009-016029-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016029-32.